Abstract
Intranasal midazolam offers an attractive alternative for use as a sedative agent for medical imaging studies in children. Its convenient administration and rapid onset are significant advantages over intravenous and oral agents. Because of its short duration, it is effective only for short procedures and as an adjunct to other sedative agents. When younger children present with such requirements, a dose of 0.2 mg/kg has been safe and effective in our experience. We advocate its use with adherence to guidelines for sedation published by the American Academy of Pediatrics.
Similar content being viewed by others
References
American Academy of Pediatrics, Committee on Drugs (1988) Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 89: 1110–1115
Diament MJ, Bird CR, Stanley P (1988) Outpatient performance of invasive radiologic procedures in pediatric patients. Radiology 166: 401–403
Rochette A, Julia JM, Evrard O, et al (1984) Intramuscular premedication with midazolam in infants and children. Ann Fr Anesth Réanim 3: 346–350
Tolksdorf W, Eick C (1991) Rectal, oral and nasal premedication using midazolam in children aged 1–6 years. A comparative clinical study. Anaesthesist 40: 661–667
Theroux MC, West DW, Corddry DH et al (1993) Efficacy of intransal midazolam in facilitating suturing of lacerations in preschool children in the emergency department. Pediatrics 91: 624–627
Twersky RS, Hartung J, Berger BJ et al (1993) Midazolam enhances anterograde but not retrograde amnesia in pediatric patients. Anesthesiology 78:51–55
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harcke, H.T., Grissom, L.E. & Meister, M.A. Sedation in pediatric imaging using intranasal midazolam. Pediatr Radiol 25, 341–343 (1995). https://doi.org/10.1007/BF02021697
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02021697